About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Analysis of a New Biomarker for Prostate Cancer Diagnosis

NCT01819740·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Miriam Barrio-Muñoz
CONTACT
34 93 723 10 10 [email protected]

Lead

Corporacion Parc Tauli

Age

45–75

Sex

MALE

Healthy volunteers

Not accepted

You may be eligible if

Clinical or laboratory suspected of prostate cancer

You may not be if

Inability to ejaculate

The record

StatusUnknown

PhaseNo phase

Taking part28

StartedApr 2013

UpdatedMar 28, 2013

Conditions

Patients With Suspected Prostate Cancer

Where1

Hospital Universitario Parc Taulí
Sabadell, Barcelona, Spain

Clareo Health | Analysis of a New Biomarker for Prostate Cancer Diagnosis